Diab Longevity

The Executive Asset Review delivers four hospital-grade diagnostics in a single session. Dr. Diab conducts a Full Body MRI, genomics analysis, AI cardiac analysis, and a complete metabolic panel. The session produces a quantified picture of your biological age with clinical precision. Diab Longevity designs this review specifically for executives who want a comprehensive baseline, not a routine check-up.

Diab Longevity organizes care into three tracks. BUILD focuses on structural restoration through stem cell signaling, exosome infusions, and joint repair. PERFORMANCE targets metabolic output using peptide therapy, hormone calibration, and Retatrutide. RETURNS pursues long-term biological preservation through telomere monitoring, inflammation control, and biological age reversal. Dr. Diab uses an initial optimization review to determine which track fits your biology.

DiabOS is a proprietary health performance dashboard that Dr. Diab developed to give clients real-time visibility into their biological data. The platform pulls in data from wearables like Oura and Apple Watch, LabCorp lab results, and DNA analysis. It displays this information as a live biomarker balance sheet. The Anti-Normal Audit Engine flags sub-optimal trends in markers like ApoB, hs-CRP, and testosterone that standard medicine would mark as normal. Clients also access Dr. Diab directly through the Ask Diab secure messaging feature.

Diab Longevity operates as a performance health platform outside the standard insurance framework. The practice benchmarks clients against elite performance standards rather than the population averages that insurance-based medicine uses. Clients should contact the practice directly to discuss membership and pricing details.

Yes, Diab Longevity offers telemedicine visits. Remote access fits naturally into the DiabOS model, which keeps clients connected to Dr. Diab between in-person sessions. Clients can reach Dr. Diab directly through the Ask Diab secure messaging feature for lab questions, protocol updates, and real-time guidance.

Diab Longevity uses proprietary performance benchmarks drawn from elite athlete and high-performance executive data. 5 mg/L, ApoB below 60 mg/dL, Vitamin D at 80-100 ng/mL, and VO2 Max in the top 5% for age. These targets exceed standard lab reference ranges by a significant margin. Dr. Diab designs protocols specifically to reach and maintain those elite thresholds.

Diab Longevity works with high-performing adults, including CEOs, executives, and top-tier performers who want proactive biological management. The practice focuses on adults who hold themselves to elite performance standards and want their health managed with the same rigor. Research cited by the practice shows that 73% of executives carry at least one silent, undiagnosed risk factor.

Dr. Diab offers several stem cell and regenerative protocols under the BUILD track. These include MSC Signaling Therapy, Exosome Messenger Infusion, and VSEL Joint Restoration. The practice conducts this work under IRB-2024-0847 and maintains GMP compliance. The clinical goal is functional restoration of structural tissue, not cosmetic improvement.

Prospective clients begin with an optimization review to identify which clinical track matches their biology. From there, Dr. Diab designs a protocol using the DiabOS platform as the ongoing management tool. You can reach the practice directly at (954) 947-1788 to schedule your initial review.